Life Sciences & Biotech

Innovating in the Life Sciences and Biotech sector is a particularly demanding challenge. The progressive enlargement of the legal boundaries of intellectual property, the constant update of the relevant legislation and the stricter control standards make increasingly difficult to predict whether a new product will obtain results in line with the investments. Therefore, intellectual property strategies are needed to protect biopharmaceuticals, diagnostic products and services, biotechnologies for agriculture, bioinformatics, vaccines, microfluidic science, genetic technologies and products.